Income Positive Again, Sales Weak

For the fiscal fourth quarter 2020 Musclepharm Corp earnings turn positive of $0.06 per share compare to $-0.11 a year ago and eps more than doubled by 459.88 % from $0.01 per share from the previous quarter.

Sales declined in double digits by -13.13 % to $15 millions from $17 millions in the same quarter a year ago and sequentially Sales decreased by -5.93 % from $16 millions.



Company achieved net income of $2.820 millions in the fiscal fourth quarter 2020 an improvement versus a net loss of $-3.459 millions in the same quarter a year ago. Musclepharm Corp also emphasized it's improving profit margins, where net margin rose to 18.64% in fiscal fourth quarter 2020, and operating margin edged up to 7.04%.
Musclepharm Corp reported earnings of $3 millions and Sales of $64 millions for the fiscal year 2020.

Company reported earnings per share of $0.08 compare to $-0.92 in the previous fiscal year, while Sales fell by -19.11 % from $80 millions a year ago.

Musclepharm Corp is expected to report next financial results on May 10, 2021.